Author(s): Moretti DV, Frisoni GB, Fracassi C, Pievani M, Geroldi C, et al.
The theta/gamma and alpha3/alpha2 ratio were investigated as early markers for prognosticating of progression to dementia. 76 subjects with mild cognitive impairment (MCI) underwent EEG recording, MRI scans and neuropsychological (NPS) tests. After 3 years of follow-up, three subgroups were characterized as converters to Alzheimer's disease (AD, N=18), converters to non-AD dementia (N=14) and non-converters (N=44). The theta/gamma and alpha3/alpha2 ratio, performance on cognitive tests and hippocampal volume, as evaluated at the time of initial MCI diagnosis, were studied in the three groups. As expected, MCI to AD converters had the smallest mean hippocampal volume and poorest performance on verbal learning tests, whereas MCI to non-AD converters had poorest cognitive performance in non-verbal learning tests, abstract thinking, and letter fluency. Increased theta/gamma ratio was associated with conversion to both AD and non-AD dementia; increased alpha3/alpha2 ratio was only associated with conversion to AD. Theta/gamma and alpha3/alpha2 ratio could be promising prognostic markers in MCI patients. In particular, the increase of high alpha frequency seems to be associated with conversion in AD. EEG markers allow a mean correct percentage of correct classification up to 88.3%. Future prospective studies are needed to evaluate the sensitivity and specificity of these measures for predicting an AD outcome.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/20022139
Author(s): Stam CJ, van der Made Y, Pijnenburg YA, Scheltens P
Author(s): Rossini PM, Buscema M, Capriotti M, Grossi E, Rodriguez G, et al.
Author(s): Moretti DV, Pievani M, Geroldi C, Binetti G, Zanetti O, et al.
Author(s): Rochat L, Delbeuck X, Billieux J, d'Acremont M, Van der Linden AC, et al.
Author(s): Rochat L, Billieux J, Juillerat Van der Linden AC, Annoni JM, Zekry D, et al.
Author(s): Basar K, Sesia T, Groenewegen H, Steinbusch HW, Visser-Vandewalle V, et al.
Author(s): McClure SM, Ericson KM, Laibson DI, Loewenstein G, Cohen JD
Author(s): Boettiger CA, Mitchell JM, Tavares VC, Robertson M, Joslyn G, et al.
Author(s): Weber BJ, Huettel SA
Author(s): Wittmann M, Leland DS, Churan J, Paulus MP
Author(s): Kuhnen CM, Knutson B
Author(s): Moretti DV, Paternicò D, Binetti G, Zanetti O, Frisoni GB
Author(s): Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL
Author(s): Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A
Author(s): Moretti DV, Babiloni F, Carducci F, Cincotti F, Remondini E, et al.
Author(s): Moretti DV, Babiloni C, Binetti G, Cassetta E, Dal Forno G, et al.
Author(s): Moretti DV, Frisoni GB, Pievani M, Rosini S, Geroldi C, et al.
Author(s): Moretti DV, Pievani M, Fracassi C, Geroldi C, Calabria M, et al.
Author(s): Moretti DV, Fracassi C, Pievani M, Geroldi C, Binetti G, et al.
Author(s): Moretti DV, Pievani M, Fracassi C, Binetti G, Rosini S, et al.
Author(s): Klimesch W
Author(s): Klimesch W
Author(s): Ashburner J
Author(s): de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, et al.
Author(s): Cherubini A, Péran P, Spoletini I, Di Paola M, Di Iulio F, et al.
Author(s): Zarei M, Patenaude B, Damoiseaux J, Morgese C, Smith S, et al.
Author(s): Cabeza R, Daselaar SM, Dolcos F, Prince SE, Budde M, et al.